Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60 to 85 years in a randomized, double-blind, phase 1 study.
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:1341-321X
-
Container-title:Journal of Infection and Chemotherapy
-
language:en
-
Short-container-title:Journal of Infection and Chemotherapy
Author:
Haranaka MiwaORCID,
Momose AtsushiORCID,
Nakayama YoshikazuORCID,
Saito Yuki,
Spiessens Bart,
Davies Todd A.,
Dobbelsteen Germie van denORCID,
Poolman Jan,
Sarnecki MichalORCID
Funder
Janssen Japan
Janssen Pharmaceutica